Company news
Jointown Pharmaceutical Group Co., Ltd. news in 2026
Jointown Pharmaceutical Group Co., Ltd.'s news releases, calls and decks from 2026, newest first.
Announcement on Subsidiary's Drug Passing Generic Drug Consistency Evaluation
May 26, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 21, 2026
Indicative Announcement on Convening the 2025 Annual General Meeting
May 14, 2026
Announcement on Recognition of Subsidiary as High-tech Enterprise
May 12, 2026
Announcement on Subsidiary's Passing GMP Compliance Inspection for Drugs
May 6, 2026
Announcement on Holding Subsidiary Certified as High-tech Enterprise
April 29, 2026
Report for Q1 2026
April 27, 2026
Announcement on Results of Issuing Phase II Ultra-Short-Term Financing Bonds of 2026
April 23, 2026
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Azelastine Hydrochloride Nasal Spray
April 21, 2026
Announcement on Temporary Idle Funds’ Investment Management Arrangements for Q1 2026
April 8, 2026
Announcement on Receipt of the "Notice of Registration Acceptance" from the National Association of Financial Market Institutional Investors
April 2, 2026
Announcement on Obtaining Medical Device Registration Certificate by Holding Subsidiary
March 24, 2026
Announcement on the Results of Issuance of the 2026 Phase II Science and Technology Innovation Bonds
March 11, 2026
Announcement on Advance Release and Pledge of Shares by the Controlling Shareholder and Its Persons Acting in Concert
February 10, 2026
Announcement on the Subsidiary Receiving the "Acceptance Notice" from the National Medical Products Administration for the Market Application of Betahistine Hydrochloride Tablets
February 6, 2026
Announcement on Completion of Industrial and Commercial Change Registration and Filing of Articles of Association
January 22, 2026
Announcement on the Results of Issuance of the 2026 Phase I Science and Technology Innovation Bonds
January 21, 2026
Announcement on Entrusted Financial Management in Q4 2025
January 16, 2026
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
January 7, 2026
Announcement on Obtaining Drug Registration Certificate for Bupivacaine Hydrochloride Injection
January 6, 2026
Announcement on Provision of Online Voting Reminder Service for General Meeting
January 4, 2026